ESSA Pharma Inc (NASDAQ:EPIX) (TSE:EPI) shares traded up 10.5% on Thursday . The company traded as high as $3.06 and last traded at $3.06, 103,721 shares traded hands during mid-day trading. An increase of 513% from the average session volume of 16,923 shares. The stock had previously closed at $2.77.
A number of equities research analysts recently weighed in on the company. HC Wainwright restated a “buy” rating on shares of ESSA Pharma in a report on Friday, May 17th. ValuEngine cut ESSA Pharma from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Zacks Investment Research raised ESSA Pharma from a “sell” rating to a “buy” rating and set a $2.50 target price on the stock in a research note on Wednesday, May 22nd.
The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 2.27. The business has a 50 day moving average of $2.21 and a 200-day moving average of $2.63. The stock has a market cap of $22.38 million, a PE ratio of -1.20 and a beta of 1.85.
ESSA Pharma Inc, a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More: Certificate of Deposit (CD)
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.